DL-carnitine hydrochloride in an IL1-stimulated MMP13 expression screen
Cell-based study · Human SW1353 chondrosarcoma cell line [1]
In a single-concentration thesis screen, DL-carnitine hydrochloride increased IL1-induced MMP13 mRNA relative to IL1 alone.
| Endpoint | Reported result | Reference |
|---|---|---|
| MMP13 gene expression normalized to 18S and expressed relative to IL1-only control | Direction and reported statistical significance Increased; p<0.05 indicated for compound 38; mean ± SEM, n=3. Exact fold change not extracted. | [1] |
Literature-Reported Treatment Conditions
- Treatment concentration
- 10 μM
- Exposure duration
- 1 h compound pretreatment; 6 h IL1 stimulation as specified in Figure 3.3 caption
- Method
- Cell treatment followed by qRT-PCR
- Vehicle
- DMSO stock reported; final DMSO concentration and vehicle matching are not explicitly specified in the selected screen description
- Co-treatment
- IL1, 5 ng/ml; comparator IL1 alone
- Reported limits
- n=3 is not identified as biological versus technical replication in Figure 3.3. Exact final solvent control matching is unverified; endpoint is transcript expression, not MMP13 enzyme activity.
Methods and source locations
Compound reported in the paper: DL-carnitine hydrochloride; Compound label in the paper: Compound 38
Limited to the reported single-concentration cell-line screen in a doctoral thesis; no disease efficacy or direct molecular target claim.
printed pp.50–54,60,64–65; appendix p.209
MMP13 gene expression normalized to 18S and expressed relative to IL1-only control: qRT-PCR; one-way ANOVA with Dunnett’s post hoc test per Figure 3.3 caption — printed p.65, section 3.2.3.1, Figure 3.3 and caption; appendix p.209, compound 38